Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas
Primary cutaneous lymphomas are a heterogeneous group of T-and B-cell lymphomas that
present in the skin with no evidence of extracutaneous disease at the time of diagnosis. The …
present in the skin with no evidence of extracutaneous disease at the time of diagnosis. The …
The biology and management of systemic anaplastic large cell lymphoma
G Hapgood, KJ Savage - Blood, The Journal of the American …, 2015 - ashpublications.org
Systemic anaplastic large cell lymphoma (ALCL) is an aggressive CD30+ non-Hodgkin
lymphoma. Anaplastic lymphoma kinase–positive (ALK+) ALCL is associated with the NPM …
lymphoma. Anaplastic lymphoma kinase–positive (ALK+) ALCL is associated with the NPM …
Genomic profiling for clinical decision making in lymphoid neoplasms
With the introduction of large-scale molecular profiling methods and high-throughput
sequencing technologies, the genomic features of most lymphoid neoplasms have been …
sequencing technologies, the genomic features of most lymphoid neoplasms have been …
Oncogenic activation of the STAT3 pathway drives PD-L1 expression in natural killer/T-cell lymphoma
TL Song, ML Nairismägi, Y Laurensia… - Blood, the Journal of …, 2018 - ashpublications.org
Mature T-cell lymphomas, including peripheral T-cell lymphoma (PTCL) and extranodal
NK/T-cell lymphoma (NKTL), represent a heterogeneous group of non-Hodgkin lymphomas …
NK/T-cell lymphoma (NKTL), represent a heterogeneous group of non-Hodgkin lymphomas …
Molecular heterogeneity in peripheral T-cell lymphoma, not otherwise specified revealed by comprehensive genetic profiling
Y Watatani, Y Sato, H Miyoshi, K Sakamoto, K Nishida… - Leukemia, 2019 - nature.com
Peripheral T-cell lymphoma, not otherwise specified (PTCL, NOS) is a diagnosis of
exclusion, being the most common entity in mature T-cell neoplasms, and its molecular …
exclusion, being the most common entity in mature T-cell neoplasms, and its molecular …
ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes
ER Parrilla Castellar, ES Jaffe, JW Said… - Blood, The Journal …, 2014 - ashpublications.org
Anaplastic lymphoma kinase (ALK)-negative anaplastic large cell lymphoma (ALCL) is a
CD30-positive T-cell non-Hodgkin lymphoma that morphologically resembles ALK-positive …
CD30-positive T-cell non-Hodgkin lymphoma that morphologically resembles ALK-positive …
Genomic analysis of mycosis fungoides and Sézary syndrome identifies recurrent alterations in TNFR2
A Ungewickell, A Bhaduri, E Rios, J Reuter, CS Lee… - Nature …, 2015 - nature.com
Mycosis fungoides and Sézary syndrome comprise the majority of cutaneous T cell
lymphomas (CTCLs), disorders notable for their clinical heterogeneity that can present in …
lymphomas (CTCLs), disorders notable for their clinical heterogeneity that can present in …
Lymphoma classification update: T-cell lymphomas, Hodgkin lymphomas, and histiocytic/dendritic cell neoplasms
M Jiang, NN Bennani, AL Feldman - Expert review of hematology, 2017 - Taylor & Francis
Introduction: Lymphomas are classified based on the normal counterpart, or cell of origin,
from which they arise. Because lymphocytes have physiologic immune functions that vary …
from which they arise. Because lymphocytes have physiologic immune functions that vary …
[HTML][HTML] Breast implant-associated anaplastic large cell lymphoma: a review
Breast implant-associated anaplastic large cell lymphoma is a newly recognized provisional
entity in the 2017 revision of the World Health Organization Classification of Tumors of …
entity in the 2017 revision of the World Health Organization Classification of Tumors of …
DUSP22 and TP63 rearrangements predict outcome of ALK-negative anaplastic large cell lymphoma: a Danish cohort study
MB Pedersen, SJ Hamilton-Dutoit… - Blood, The Journal …, 2017 - ashpublications.org
Peripheral T-cell lymphomas (PTCLs) represent a group of rare hematological cancers of
mature T-cell or natural killer cell origin accounting for 10% to 15% of all lymphomas. 1 …
mature T-cell or natural killer cell origin accounting for 10% to 15% of all lymphomas. 1 …